the-infoshop.com - The vertical markets research portal
View CartView Cart
Global Information, Inc.
US: +1-860-674-8796
EU: +32-2-535-7543
SG: +65-6223-2436
  Home | Category | Publishers | Custom Research | E-mail Alert | About Us | Contact Us | Site Map |
 

* View All Categories
View Conferences
Japanese Korean Chinese

Market Research Report

How to Forecast Generic Pharmaceutical Prices

Published by Urch Publishing, Ltd. Contact us : +1-860-674-8796
Published 2009/03 Content info  
Product code UR83659
Price From  US $ 3920 Order/Price list
US $ 3920 PDF by E-mail (Single User License)
Delivery Time
PDF by E-Mail
Approx. 1-2 business days
Hard Copy/CD-ROM
Approx. 3-4 business days
If you need expedited delivery, please call us.
Description TOC

Abstract

Summary

“Finally. A model for predicting the price fall of generics  proven to have worked for 99% of drugs”

It has long been recognised that prices paid by chemists and doctors for a generic product decline in the weeks and months after generic launch and patent expiry. But calculating how quickly this happens can often only be guessed at - until now

How to Forecast Generic Pharmaceutical Prices - A practical method to estimate future generic product prices is a unique guide that will help you be able to forecast future generic prices before and after launch.

Specifically designed to be instantly usable, this publication, presents a tried and tested methodology to predict how the price of a generic medicine will fall after patent expiry and launch.

The practical guide, which is produced by URCH Publishing in association with WaveData, a medical price analysis company, will allow users to build spreadsheets and forecast products prices as required.

The model presented is based on solid methodology drawing from over 6 year' s work (over 60,000 hours) cataloguing 6 million pharmaceutical prices. A 120 real-life examples of generic product were studied to find patterns of price decay.

The model takes into account both regional drug reimbursement policies and the brand value of the product.

20 tables provide detailed percentage points according to the number of generic licence holders entering the marketplace post patent-expiry.

The model works in the absence of government price capping, where the price decay happens as a result of competition between suppliers (free pricing) rather than statuary price reductions, and the reimbursement price is high enough to allow free pricing.

5 Reasons to Invest in this Report

  • Stop using “rule of thumb” to calculate the decline in price
  • Adopt the suggested methodology immediately
  • Easily understandable, designed for the non-statistician
  • Follow clear instructions to build your own spreadsheet models
  • Adjust the number of expected competitors with first 3 years of launch

This unique guide is a must have for all:

  • Pricing and reimbursement executives
  • Marketing Managers in Generic Drug Companies
  • Strategy directors in pharmaceutical companies
  • Consultancies with an interest in pharmaceutical markets

Buy this model and get a year' s FREE subscription to PROfesy CR an online modelling tool to forecast generic erosion.

Related Report
Back to Top
Please inform me when related publications are released
InfoWatch

US: 1-860-674-8796 EU: 32-2-535-7543 SG: 65-6223-2436
The vertical markets research portal
© 2009, the-infoshop.com by Global Information, Inc. All rights reserved.